This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Francis, G. S. Articles by Archer, S. L. Search for Related Content PubMed Articles by Francis, G. S. Articles by Archer, S. L. Social Bookmarking                         What's this?

Diagnosis and Management of Acute Congestive Heart Failure in the Intensive Care Unit

Department of Medicine, Division of Cardiology, Veterans Administration Medical Center, and The University of Minnesota Medical School, Minneapolis, MN

Stephen L. Archer, MD

Department of Medicine, Division of Cardiology, Veterans Administration Medical Center, and The University of Minnesota Medical School, Minneapolis, MN

Congestive heart failure has emerged as an important public health problem in the United States and is pres ently the number one Diagnostic Related Group for inpatients over the age of 65. Patients admitted to an intensive care or coronary care unit because of de compensated heart failure are frequently older and frequently have multiple serious medical problems. In addition to standard intensive care practices, it is often important to characterize systolic and diastolic proper ties qualitatively with echocardiography. Hemodynamic monitoring is essential for patients with hypotension, oliguria, or questionable left ventricular filling pressures. A combination of loop diuretics, intravenous vaso dilators, and inotropic agents will often be necessary to correct severe underlying hemodynamic abnormalities, and an understanding of basic left ventricular systolic and diastolic function is essential to the optimal use of these potent agents. Manipulation of loading conditions and contractile state are important considerations, and pharmacological interventions should be targeted to ward specific abnormalities in individual patients. Once patients are stabilized, switching to orally active inotro pic and vasodilator agents can usually be accomplished over a 24-hour period, allowing for a total stay of 48 to 72 hours in the intensive care unit.

Congestive heart failure (CHF) is rapidly becoming a public health problem of major proportions [1- 5]. As the American population continues to age, we can expect greater numbers of patients to be admitted to intensive care units (ICUs) and coro nary care units (CCUs) with progressive decompen sation of previously stable CHF. Our current ap proaches to the diagnosis and management of acute heart failure are summarized; however, the care of such patients must always be highly individualized.

Journal of Intensive Care Medicine, Vol. 4, No. 2, 84-92 (1989)
DOI: 10.1177/088506668900400206


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. V. Leier Congestive Heart Failure: Evolving a Better Understanding of Therapeutic Regimens J Intensive Care Med, March 1, 1989; 4(2): 51 - 52. [PDF]